Science Explorer Interactive view Map
Company · Toronto · Canada

Trillium Therapeutics (Canada)

Research works
61
▲ 24% vs 2013–17
Citations
1.1k
17.7 per fractional work
Top-10% rate
16.8%
record average 16.5%
Open access
36%
world 28%

Not ranked overall: Trillium Therapeutics (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.06× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.05× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 24.87× its world share, 3 worksImmunology and Micro…Neuroscience: 2.20× its world share, 0 worksNeuroscienceComputer Science: 0.43× its world share, 0 worksComputer ScienceEngineering: 0.16× its world share, 0 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.05× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.75× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.50× its world share, 0 worksHealth ProfessionsMedicine: 2.58× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.39× its world share, 0 worksBusiness, Management…Decision Sciences: 0.66× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.39× its world share, 0 worksEconomics, Econometr…Psychology: 0.66× its world share, 0 worksPsychologySocial Sciences: 0.14× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 24.9×. Every wedge is a field page.

Which keywords describe research at Trillium Therapeutics (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Ethical Considerations, Transplantation, Macrophages, Immune Regulation, Kidney Transplantation, apoptotic cells and CD47.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer Immunotherapy7▲ 81×3 topics
  2. Inflammation5▲ 3.6×16 topics
  3. Ethical Considerations5▲ 24×3 topics
  4. Transplantation4▲ 64×3 topics
  5. Macrophages4▲ 42×2 topics
  6. Immune Regulation4▲ 52×2 topics
  7. Kidney Transplantation4▲ 98×2 topics
  8. CD474▲ 433×1 topic
  9. apoptotic cells4▲ 433×1 topic
  10. Immunity4▲ 18×4 topics
  11. Cancer3▲ 3.8×8 topics
  12. Living Kidney Donors3▲ 185×1 topic
  13. Organ Donation3▲ 185×1 topic
  14. Graft Survival3▲ 48×2 topics
  15. Innate Immunity3▲ 14×4 topics
  16. NK Cell Recognition3▲ 45×1 topic
  17. Natural Killer Cells3▲ 45×1 topic
  18. Metabolism3▲ 6.6×3 topics
  19. Ischemia-Reperfusion Injury2▲ 42×2 topics
  20. Immunotherapy2▲ 5.8×3 topics
  21. Tumor Regression2▲ 43×2 topics
  22. Activation2▲ 105×1 topic
  23. Liver Transplantation2▲ 24×2 topics
  24. Macrophage2▲ 65×1 topic
  25. Autoimmunity2▲ 16×2 topics
  26. Biliary Complications2▲ 62×1 topic
  27. Donor Risk Index2▲ 62×1 topic
  28. Immunosuppressive Therapy2▲ 17×5 topics
  29. Foxp32▲ 41×1 topic
  30. TGF-ß2▲ 18×1 topic
  31. Lymphoma2▲ 20×2 topics
  32. CAR T Cells2▲ 61×1 topic
  33. Chimeric Antigen Receptor2▲ 61×1 topic
  34. Gene Therapy2▲ 9.5×3 topics
  35. Health Care Costs2▲ 31×2 topics
  36. Antigen Presentation1▲ 23×2 topics
  37. Dendritic Cells1▲ 20×2 topics
  38. End-of-Life1▲ 28×1 topic
  39. Palliative Care1▲ 14×1 topic
  40. Rejection1▲ 45×2 topics

Which research topics does Trillium Therapeutics (Canada) publish most on?

By volume in 2022–2025: Organ Donation and Transplantation, T-cell and B-cell Immunology, Immune Cell Function and Interaction and Palliative Care and End-of-Life Issues.

  1. 1 Organ Donation and Transplantation Public Health, Environmental and Occupational Health 1 works
  2. 2 T-cell and B-cell Immunology Immunology 1 works
  3. 3 Immune Cell Function and Interaction Immunology 1 works
  4. 4 Palliative Care and End-of-Life Issues Public Health, Environmental and Occupational Health 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Organ Transplantation Techniques and Outcomes Surgery 0 works
  7. 7 Phagocytosis and Immune Regulation Immunology 0 works
  8. 8 Neuropeptides and Animal Physiology Cellular and Molecular Neuroscience 0 works
  9. 9 Treatment of Major Depression Pharmacology 0 works
  10. 10 Chemokine receptors and signaling Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.6%not open64.4%

World: 28% of research is openly available.

with international co-authors35.6%domestic only64.4%

World: 19% is written across borders.

How has Trillium Therapeutics (Canada)'s research output changed?

Output in 2018–2022 was 24% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Toronto

All research institutions in Toronto

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.